Skip to main content

Table 1 Clinical features of 57 patients with KTs of colorectal origin

From: Clinical analysis of Krukenberg tumours in patients with colorectal cancer—a review of 57 cases

 

Number (N = 57)

Percentage

Primary colorectal carcinoma

 Age at diagnosis of primary colorectal carcinoma

  <60 years

43

75.4

  ≥60 years

14

24.6

 Primary tumour site

  Sigmoid colon

19

33.3

  Rectum

11

19.3

  Ascending colon

9

15.8

  Caecum colon

8

14.0

  Transverse colon

5

8.8

  Descending colon

3

5.3

  Multiple sites

2

3.5

 Tumour histology

  Well differentiated

19

33.3

  Moderately differentiated

21

36.8

  Poorly differentiated

11

19.3

  Undifferentiated

6

10.5

 Depth of tumour invasion

  T3

21

36.8

  T4

36

63.2

 Primary lymph node metastasis

  Retroperitoneal lymph node metastasis

16

36.8

  Non-retroperitoneal lymph node metastasis

20

35.1

  None

21

28.1

Ovarian metastatic tumours

 Age at diagnosis of ovarian metastases

  <60 years

40

70.2

  ≥60 years

17

29.8

 Menses

  Pre-menopausal

32

56.1

  Post-menopausal

25

43.9

 Primary site

  Ovarian mass

18

31.6

  Abdominal pain

14

24.6

  Abdominal distension

11

19.3

  Incidentally discovered during operation

8

14.0

  Irregular vaginal bleeding

6

10.5

 Timing of ovarian metastasis

  Synchronous

21

36.8

  13–24 months

23

40.4

  >24 months

13

22.8

 Tumour size

  ≤10 cm

33

57.9

  >10 cm

24

42.1

 Ovarian involvement

  Unilateral

21

36.8

  Bilateral

36

63.2

 Extent of metastatic disease

   M ovary

28

49.1

  M1

14

24.6

  M2

15

26.3

 Extent of surgery

  Minimal

17

29.8

  Extensive

40

70.2

 Completeness of cytoreduction

  CC0

26

45.6

  CC1

16

28.1

  CC2

15

26.3

 Systemic chemotherapy

  Yes

34

59.6

  No

23

40.4

  1. Note: CC0 and CC1 are described as complete cytoreduction, CC2 as incomplete cytoreduction
  2. CC0 no macroscopic residual tumour, CC1 maximal diameter of residual tumour <2.5 mm, CC2 maximal diameter of residual tumour ≥2.5 mm, M ovary ovary-only metastasis, M1 metastasis confined to the pelvis, M2 metastasis beyond the pelvis